| The pathophysiology of sepsis-associated AKI S Kuwabara, E Goggins, MD Okusa Clinical Journal of the American Society of Nephrology 17 (7), 1050-1069, 2022 | 58 | 2022 |
| Clinical perspectives on vagus nerve stimulation: present and future E Goggins, S Mitani, S Tanaka Clinical Science 136 (9), 695-709, 2022 | 32 | 2022 |
| Metabolic consequences of HIF silencing in a triple negative human breast cancer xenograft SK Bharti, Y Mironchik, F Wildes, MF Penet, E Goggins, ... Oncotarget 9 (20), 15326, 2018 | 31 | 2018 |
| Dihydroartemisinin–Ferriprotoporphyrin IX Adduct Abundance in Plasmodium falciparum Malarial Parasites and the Relationship to Emerging Artemisinin Resistance LE Heller, E Goggins, PD Roepe Biochemistry 57 (51), 6935-6945, 2018 | 30 | 2018 |
| Hypoxia inducible factors modify collagen I fibers in MDA-MB-231 triple negative breast cancer xenografts E Goggins, S Kakkad, Y Mironchik, D Jacob, F Wildes, B Krishnamachary, ... Neoplasia 20 (2), 131-139, 2018 | 24 | 2018 |
| Molecular and functional imaging insights into the role of hypoxia in cancer aggression S Kakkad, B Krishnamachary, D Jacob, J Pacheco-Torres, E Goggins, ... Cancer and Metastasis Reviews 38, 51-64, 2019 | 23 | 2019 |
| Sphingosine 1-phosphate signaling in perivascular cells enhances inflammation and fibrosis in the kidney S Tanaka, S Zheng, Y Kharel, RG Fritzemeier, T Huang, D Foster, ... Science translational medicine 14 (658), eabj2681, 2022 | 22 | 2022 |
| Hypoxia theranostics of a human prostate cancer xenograft and the resulting effects on the tumor microenvironment B Krishnamachary, Y Mironchik, D Jacob, E Goggins, S Kakkad, F Ofori, ... Neoplasia 22 (12), 679-688, 2020 | 18 | 2020 |
| EXPLORing exosomes for the treatment of acute kidney injury E Goggins, S Tanaka Kidney International 100 (3), 508-510, 2021 | 5 | 2021 |
| Neuroimmune circuits activated by vagus nerve stimulation S Kuwabara, E Goggins, S Tanaka Nephron 146 (3), 286-290, 2022 | 4 | 2022 |
| Reprogramming of VEGF-mediated extracellular matrix changes through autocrine signaling E Goggins, Y Mironchik, S Kakkad, D Jacob, F Wildes, ZM Bhujwalla, ... Cancer Biology & Therapy 24 (1), 2184145, 2023 | 3 | 2023 |
| Long‐term humoral immunity decline in hemodialysis patients following severe acute respiratory syndrome coronavirus 2 vaccination: a cohort study E Goggins, B Sharma, JZ Ma, J Gautam, B Bowman Health Science Reports 5 (6), e854, 2022 | 3 | 2022 |
| Long term humoral immunity decline in hemodialysis patients following SARS-CoV-2 vaccination E Goggins, B Sharma, JZ Ma, J Gautam, B Bowman MedRxiv, 2021.12. 01.21265957, 2021 | 3 | 2021 |
| SARS‐CoV‐2 booster effect and waning immunity in hemodialysis patients: A cohort study E Goggins, B Sharma, JZ Ma, J Gautam, B Bowman Health Science Reports 6 (1), 2023 | 1 | 2023 |
| Introducing M Blagosklonny, A Gudkov, SK Bharti, Y Mironchik, F Wildes, MF Penet, ... OncoTarget. Oncotarget 1, 2, 2010 | 1 | 2010 |
| Humoral immunity trends in a hemodialysis cohort following SARS‐CoV‐2 mRNA booster: A cohort study E Goggins, B Sharma, JZ Ma, J Gautam, B Bowman Health Science Reports 7 (2), e1858, 2024 | | 2024 |
| Downregulation of glutamine transporter stably and significantly attenuates weight loss by a cachexia-inducing pancreatic cancer xenograft B Krishnamachary, I Sivakumar, Y Mironchik, RK Sharma, SK Bharti, ... Cancer Research 82 (12_Supplement), 6305-6305, 2022 | | 2022 |
| SARS-CoV-2 Booster Effect and Waning Immunity in Hemodialysis Patients E Goggins, B Sharma, JZ Ma, J Gautam, B Bowman medRxiv, 2022.05. 22.22275183, 2022 | | 2022 |
| SARS-CoV-2 Booster Effect and Waning Immunity in Hemodialysis Patients (preprint) E Goggins, B Sharma, J Gautam, JZ Ma, B Bowman | | 2022 |
| Downregulating the glutamine transporter, SLC1A5, significantly reduces cachexia in a PDAC xenograft B Krishnamachary, I Sivakumar, Y Mironchik, RK Sharma, SK Bharti, ... Cancer Research 81 (13_Supplement), 2354-2354, 2021 | | 2021 |
